Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Giovanni Guaraldi and Marianna Meschiari.
Giovanni Guaraldi
Connection Strength
2.878
Marianna Meschiari
  1. The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models. Open Forum Infect Dis. 2021 Jul; 8(7):ofab283.
    View in: PubMed
    Score: 0.238
  2. Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia. AIDS Res Hum Retroviruses. 2021 04; 37(4):283-291.
    View in: PubMed
    Score: 0.234
  3. Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1141.
    View in: PubMed
    Score: 0.233
  4. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
    View in: PubMed
    Score: 0.233
  5. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford). 2020 12 01; 59(12):e147-e150.
    View in: PubMed
    Score: 0.229
  6. Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency. PLoS One. 2020; 15(11):e0239172.
    View in: PubMed
    Score: 0.228
  7. Tocilizumab for severe COVID-19 pneumonia - Authors' reply. Lancet Rheumatol. 2020 Nov; 2(11):e660-e661.
    View in: PubMed
    Score: 0.224
  8. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
    View in: PubMed
    Score: 0.222
  9. The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study. PLoS One. 2021; 16(8):e0251378.
    View in: PubMed
    Score: 0.060
  10. Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection. Nat Commun. 2021 07 29; 12(1):4677.
    View in: PubMed
    Score: 0.060
  11. Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19. Clin Exp Nephrol. 2021 Nov; 25(11):1203-1214.
    View in: PubMed
    Score: 0.060
  12. Two Fatal Cases of Acute Liver Failure Due to HSV-1 Infection in COVID-19 Patients Following Immunomodulatory Therapies. Clin Infect Dis. 2021 07 01; 73(1):e252-e255.
    View in: PubMed
    Score: 0.060
  13. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering. J Healthc Eng. 2021; 2021:5556207.
    View in: PubMed
    Score: 0.060
  14. Acid base disorders in patients with COVID-19. Int Urol Nephrol. 2022 Feb; 54(2):405-410.
    View in: PubMed
    Score: 0.059
  15. Re: 'Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness' by Wolkewitz et al. Clin Microbiol Infect. 2021 07; 27(7):1043-1044.
    View in: PubMed
    Score: 0.059
  16. Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients. Kidney Res Clin Pract. 2021 Jun; 40(2):231-240.
    View in: PubMed
    Score: 0.059
  17. Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. Clin Microbiol Infect. 2021 Aug; 27(8):1137-1144.
    View in: PubMed
    Score: 0.058
  18. Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study. Multidiscip Respir Med. 2021 Jan 15; 16(1):737.
    View in: PubMed
    Score: 0.058
  19. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
    View in: PubMed
    Score: 0.058
  20. Hypokalemia in Patients with COVID-19. Clin Exp Nephrol. 2021 Apr; 25(4):401-409.
    View in: PubMed
    Score: 0.058
  21. Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia. EMBO Mol Med. 2020 12 07; 12(12):e13001.
    View in: PubMed
    Score: 0.057
  22. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia. Eur J Immunol. 2020 09; 50(9):1283-1294.
    View in: PubMed
    Score: 0.056
  23. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020 07 06; 11(1):3434.
    View in: PubMed
    Score: 0.056
  24. Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm. Cytometry A. 2020 07; 97(7):668-673.
    View in: PubMed
    Score: 0.055
  25. Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. Ther Adv Respir Dis. 2020 Jan-Dec; 14:1753466620951043.
    View in: PubMed
    Score: 0.054
  26. Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART. Open Forum Infect Dis. 2019 Apr; 6(4):ofz105.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.